Abstract
Transcutaneous immunization (TCI), the introduction of antigens using a topical application to intact skin, is a new technology that has both practical and immunological merits. Practically speaking, a needle-free method of vaccine delivery will decrease the risk of needle-borne diseases, reduce the complications related to physical skin penetration, improve access to vaccination by eliminating the need for trained personnel and sterile equipment, and provide a simple means for multivalent or multiple boosting immunization. The immunological implications of TCI are profound as this technique appears to target highly accessible antigen presenting cells (APC) in the skin that can be exploited for a variety of immune outcomes. It has been our experience that TCI can be reliably and reproducibly conducted with a variety of antigens to induce potent and functional immune responses. Thus, this new method may significantly impact both the delivery of vaccines and open new possibilities for manipulation of the immune response.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lycke, N. (1997) The mechanism of cholera toxin adjuvanticity. Res. Immunol. 148, 504–520.
Snider, D. P. (1995) The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins. Crit. Rev. Immunol. 15, 317–348.
Elson, C. O. and Ealding, W. (1984) Cholera toxin feeding did not induce oral tolerance in mice and abrogated oral tolerance to an unrelated protein antigen. J. Immunol. 133, 2892–2897.
Dickinson, B. L. and Clemens, J. D. (1995) Dissociation of Escherichia coliheat-labile enterotoxin adjuvanticity from ADP-ribosyltransferase activity. Infect. Immun. 63, 1617–1623.
Lobet, Y., Cluff, C. W., and Cieplak, W. (1991) Effect of site-directed mutagenic alterations on ADP-ribosyltransferase activity of the A subunit of Escherichia coli heat-labile enterotoxin. Infect. Immun. 59, 2870–2879.
Holmgren, J., Svennerholm, A-M., Jertborn, M., Clemens, J., Sack, D. A., Salenstedt, R., and Wigzell, H. (1992) An oral B subunit: whole cell vaccine against cholera. Vaccine 10, 911–914.
Tamura, S., Funato, H., Nagamine, T., Aizawa, C., and Kurata, T. (1989) Effectiveness of cholera toxin B subunit as an adjuvant for nasal influenza vaccination despite pre-existing immunity to CTB. Vaccine 7, 503–505.
Glenn, G. M., Rao, M., Matyas, G. R., and Alving, C. R. (1998) Skin immunization made possible by cholera toxin. Nature 391, 851.
Kripke, M. L., Munn, C. G., Jeevan, A., Tang, J. M., and Bucana, C. (1990) Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J. Immunol. 145, 2833–2838.
News and views (1998) Nature Medicine 4, 672.
Udey, M. C. (1997) Cadherins and Langerhans cell immunobiology. Clin. Exp. Immunol. 107(Suppl. 1), 6–8.
Roberts, M. S. and Walker, M. (1993) Water the most natural penetration enhancer, in Pharmaceutical Skin Penetration Enhancement (Walters, K. A. and Hadgraft, J., eds.), Marcel Dekker, New York, pp. 1–30.
Holbrook, K. A. and Odland, D. F. (1974) Regional differences in the thickness (cell layers) of the human stratum corneum: an ultrastructural analysis. J. Invest. Dermatol. 62, 415–422.
Berman, B., Chen, V. L., France, D. S., Dotz, W. I., and Petroni, G. (1983) Anatomical mapping of epidermal Langerhans cells densities in adults. Br. J. Dermatol. 109, 553–558.
Bergstresser, P. R., Fletcher, C. R., and Streilein, J. W. (1980) Surface densities of Langerhans cells in relation to rodent epidermal sites with special immunologi-cal properties. J. Invest. Dermatol. 74, 77–80.
Schweizer, J. (1980) Langerhans cell-free regions in orthokeratinizing sole-of-foot epidermis of the adult mouse. Arch. Dermatol. Res. 268, 157–166.
Fisher’s Contact Dermatitis, 4th ed. (1995) (Rietschel, R. L. and Fowler, J. F., eds.), Williams & Wilkins, Baltimore, MD, p. 2.
Glenn, G. M., Scharton-Kersten, T., Vassell, R., Matyas, G. R., and Alving, C. R. (1999) Transcutaneous immunization using bacterial ADP-ribosylating exotoxins as antigens and adjuvants. Infect. Immun. 67, 1000–1006.
Glenn, G. M., Scharton-Kersten, T., Vassell, R., Mallet, C. P., Hale, T. L., and Alving, C. R. (1998) Transcutaneous immunization with cholera toxin protects mice against lethal mucosal toxin challenge. J. Immunol. 161, 3212–3214.
Fairweather, N. F., Lyness, V. A., and Maskell, D. J. (1987) Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect. Immun. 55, 2541–2545.
McComb, J. A. (1964) The prophylactic dose of homologous tetanus antitoxin. N. Engl. J. Med. 270, 175–178.
Schneerson, R., Robbins, J. B., Taranger, J., Lagergard, T., and Trollfors, B. (1996) A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned. Lancet 348, 1289–1292.
Goldblatt, D., Vaz, A. R., and Miller, E. (1998) Antibody avidity as a surrogate maker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J. Infect. Dis. 177, 1112–1115.
Paul, A. and Cevc, G. (1995) Noninvasive administration of protein antigens: Transdermal immunization with bovine serum albumin in transferasomes. Vaccine Res. 3, 145–164.
Tang, D. C., Shi, Z., and Curiel, D. T. (1997) Vaccination onto bare skin. Nature 388, 729–730.
Wang, L., Lin, J., Hsieh, K., and Lin, R. (1996) Epicutaneous exposure of protein antigen indices a predominant Th2-like response with high IgE production in mice. J. Immunol. 156, 4077–4082.
Scharton-Kersten, T., Glenn, G. M., Vassell, R., Yu, J., Walwender, D., and Alving, C. R. (1999) Principles of transcutaneous immunization using cholera toxin as an adjuvant. Vaccine 17(Suppl), 537–543.
Hammond, S. A., Tsonis, C., Sellins, K., Rushlow, K., Scharton-Kersten, T., Colditz, I., and Glenn, G. M. (2000) Transcutaneous immunization of domestic animals: opportunities and challenges. Adv. Drug Delivery Rev., in press.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc.
About this protocol
Cite this protocol
Glenn, G.M., Scharton-Kersten, T., Vassell, R. (2000). Transcutaneous Immunization. In: O’Hagan, D.T. (eds) Vaccine Adjuvants. Methods in Molecular Medicine™, vol 42. Springer, Totowa, NJ. https://doi.org/10.1385/1-59259-083-7:315
Download citation
DOI: https://doi.org/10.1385/1-59259-083-7:315
Publisher Name: Springer, Totowa, NJ
Print ISBN: 978-0-89603-735-9
Online ISBN: 978-1-59259-083-4
eBook Packages: Springer Protocols